Le Lézard
Classified in: Science and technology
Subjects: Conference, Contract/Agreement, Product/Service, Trade Show

Ruckus Removes Hurdles to Digital Learning While Helping to Address the Vaping Epidemic


Ruckus Networks (now part of CommScope via acquisition) today announced two new products to complement its growing multigigabit access network portfolio. The Ruckus R750 Wi-Fi 6 access point (AP) and ICX 7150-C10ZP switch address the capacity crunch caused by the transition to digital learning. Ruckus is also announcing a new Internet of Things (IoT) ecosystem partnership with Soter Technologies to address the student health risk of vaping on school grounds.

By 2022, most primary and secondary schools will deliver 50 percent of their curriculum digitally. As schools undertake the transition to digital learning, Wi-Fi networks are quickly overtaxed due to initiatives such as 1:1 computing, bring your own device (BYOD), as well as the simultaneous growth of IoT sensor networks for building automation and security. Furthermore, the pervasive use of video for digital learning, online collaboration and campus safety exerts more capacity demand on Wi-Fi networks. To solve this capacity challenge and others like it, Ruckus is introducing the 4x4:4 R750 Wi-Fi 6 AP and the accompanying ICX 7150-C10ZP multigigabit access switch. Together, with CommScope's power-over-ethernet (PoE) cabling, these new products meet the capacity and requirements of a modern digitally-enabled school.

Additionally, to support schools' needs to effectively address what the U.S. Surgeon General refers to as a youth E-cigarette (vaping) epidemic, Ruckus is partnering with Soter Technologies, a leading vendor of sensor systems that detect vaping, smoke, and noise disturbances. With these sensors, schools are better able to monitor for E-cigarette use, including in areas, such as restrooms, where cameras cannot be placed. Ruckus has integrated Soter's FlySensetm family of real-time sensors into the Ruckus IoT Suite, enabling alerts to be sent to this centralized IoT dashboard when vaping is detected. School staff may choose to enable such an alert to trigger actions by other devices, such as a nearby hallway camera, managed by the IoT Controller, by making use of the embedded rules engine.

"Fly Sense is a tool that allows high schools and middle school administrators to respond to the growing vaping epidemic happening across the nation and internationally," said Derek Peterson, founder and CEO of Soter Technologies. "Together we will bring this important technology to more schools."

"Digital learning, the vaping epidemic and overall student safety are top of mind for school administrators and principals," said Bart Giordano, senior vice president of worldwide sales, Ruckus Networks. "Schools are turning to Ruckus to provide converged network and IoT solutions that support both their digital learning and student safety initiatives. We are committed to the primary and secondary education markets and will continue to innovate to help schools meet their digital learning, student safety and wellness objectives."

The Ruckus converged multigigabit network for schools and other capacity-challenged environments includes:

Ruckus Networks will be demonstrating these and other products and solutions at ISTE 2019, June 23-26, at the Pennsylvania Convention Center in Philadelphia, Booth #1438.

About CommScope:

CommScope (NASDAQ: COMM) and the recently acquired ARRIS and Ruckus Networks are redefining tomorrow by shaping the future of wired and wireless communications. Our combined global team of employees, innovators and technologists have empowered customers in all regions of the world to anticipate what's next and push the boundaries of what's possible. Discover more at www.commscope.com.

Follow us on Twitter and LinkedIn and like us on Facebook.
Sign up for our press releases and blog posts.

This press release includes forward-looking statements that are based on information currently available to management, management's beliefs, as well as on a number of assumptions concerning future events. Forward-looking statements are not a guarantee of performance and are subject to a number of uncertainties and other factors, which could cause the actual results to differ materially from those currently expected. In providing forward-looking statements, the company does not intend, and is not undertaking any obligation or duty, to update these statements as a result of new information, future events or otherwise.

Source: CommScope


These press releases may also interest you

at 08:05
Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today the enrollment of the first patient in a pilot study collecting patient-generated health data (PGHD) during proton radiotherapy for lung cancer in...

at 08:05
AVI Systems, the largest global audiovisual and unified collaboration systems integrator, today announced the launch of a new customer-focused offering called the AVI Experience. This initiative provides prospects and customers interested in...

at 08:05
Elite Robots, a leading supplier of collaborative robots, will exhibit its enriched range of cobots and all-in-one solutions at the upcoming Automate Show (May 6-9, Chicago), at booth 4255. After a successful 2023, in which Elite Robots experienced...

at 08:05
Edgio, the platform of choice for security, speed and simplicity at the edge, today announced the release of its Client-Side Protection solution. Designed to monitor scripts and APIs on the browser-side to prevent malicious code from exfiltrating...

at 08:05
Today, Stellar Cyber, the innovator of Open XDR, announced a new partnership with Acronis, a global leader in cybersecurity and data protection, to deliver an optimized threat detection and response solution enabling MSPs to protect on-premises,...

at 08:05
Roivant and Kinevant Sciences, a clinical-stage biopharmaceutical company developing new medicines for rare inflammatory and autoimmune diseases, today announced the successful completion of enrollment in its Phase 2 study evaluating namilumab for...



News published on and distributed by: